Abstract
The ATM-dependent accumulation of p53 and induction of p21waf1 are key events for G1 cell-cycle checkpoint arrest following DNA damage. In ATM-null AT cells, even though the p53 and p21waf1 responses are kinetically delayed and quantitatively reduced, the G1 checkpoint is virtually disrupted, suggesting that these proteins arrive too late in G1 to enforce the arrest. As the precise mechanism remains unclear, we examined the response to DNA double-strand breaks generated by γ-radiation (IR), to determine if ATM deficiency affects the cell-cycle phase regulation of these molecules. We find that, after irradiation, whereas normal LCL-N cells markedly increase their levels of p53 in all phases of the cell cycle, AT cells fail to show any p53 increase in the G1 phase. In addition, whereas in LCL-N p21waf1 is induced in G1 and G2-M, in AT cells this induction is partly seen in G2-M, but not in G1, indicating a different cell-cycle phase regulation of p53 and p21waf1 as a result of ATM deficiency. The levels and catalytic activity of the p53-targeting kinases ATR and DNA-PK in LCL-N and AT cells are very similar throughout the cell cycle, both before and after IR, thus excluding a phase-specific activity for these kinases. Collectively, our findings demonstrate that, in ATM-deficient cells, the p53-dependent p21waf1 response to DNA damage is not only quantitatively reduced, but also specifically suppressed in the G1 phase, thus providing a mechanistic explanation for the severe disruption of the G1 checkpoint in AT cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Abraham RT . (2001). Genes Dev., 15, 2177–2196.
Bakkenist CJ and Kastan MB . (2003). Nature, 421, 499–506.
Banin S, Moyal L, Shieh S, Taya Y, Anderson CW, Chessa L, Smorodinsky NI, Prives C, Reiss Y, Shiloh Y and Ziv Y . (1998). Science, 281, 1674–1677.
Bartek J and Lukas J . (2001). Curr. Opin. Cell Biol., 13, 738–747, (review).
Beamish H, Williams R, Chen P and Lavin MF . (1996). J. Biol. Chem., 271, 20486–20493.
Canman CE, Wolff AC, Chen CY, Fornace Jr AJ and Kastan MB . (1994). Cancer Res., 54, 5054–5058.
Chehab NH, Malikzay A, Appel M and Halazonetis TD . (2000). Genes Dev., 14, 278–288.
de Klein A, Muijtjens M, van Os R, Verhoeven Y, Smit B, Carr AM, Lehmann AR and Hoeijmakers JH . (2000). Curr. Biol., 10, 479–482.
Delia D, Goi K, Mizutani S, Yamada T, Aiello A, Fontanella E, Lamorte G, Iwata S, Ishioka C, Krajewski S, Reed JC and Pierotti MA . (1997). Oncogene, 14, 2137–2147.
Delia D, Mizutani S, Panigone S, Tagliabue E, Fontanella E, Asada M, Yamada T, Taya Y, Prudente S, Saviozzi S, Frati L, Pierotti MA and Chessa L . (2000). Br. J. Cancer, 82, 1938–1945.
Durocher D and Jackson SP . (2001). Curr. Opin. Cell Biol., 13, 225–231.
el-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE and Wang Y (1994). Cancer Res., 54, 1169–1174.
Goi K, Takagi M, Iwata S, Delia D, Asada M, Donghi R, Tsunematsu Y, Nakazawa S, Yamamoto H, Yokota J, Tamura K, Saeki Y, Utsunomiya J, Takahashi T, Ueda R, Ishioka C, Eguchi M, Kamata N and Mizutani S . (1997). Cancer Res., 57, 1895–1902.
Jhappan C, Yusufzai TM, Anderson S, Anver MR and Merlino G . (2000). Mol. Cell. Biol., 20, 4075–4083.
Khanna KK, Beamish H, Yan J, Hobson K, Williams R, Dunn I and Lavin MF . (1995). Oncogene, 11, 609–618.
Khanna KK and Jackson SP . (2001). Nat. Genet., 27, 247–254.
Khanna KK, Keating KE, Kozlov S, Scott S, Gatei M, Hobson K, Taya Y, Gabrielli B, Chan D, Lees-Miller SP and Lavin MF . (1998). Nat. Genet., 20, 398–400.
Kim ST, Lim DS, Canman CE and Kastan MB . (1999). J. Biol. Chem., 274, 37538–37543.
Lakin ND, Hann BC and Jackson SP . (1999). Oncogene, 18, 3989–3995.
Sarkaria JN, Busby EC, Tibbetts RS, Roos P, Taya Y, Karnitz LM and Abraham RT . (1999). Cancer Res., 59, 4375–4382.
Sarkaria JN, Tibbetts RS, Busby EC, Kennedy AP, Hill DE and Abraham RT . (1998). Cancer Res., 58, 4375–4382.
Shieh SY, Ikeda M, Taya Y, Prives C . (1997). Cell, 91, 325–334.
Shiloh Y . (2003). Nat. Rev. Cancer, 3, 155–168.
Shiloh Y and Kastan MB . (2001). Adv. Cancer Res., 83, 209–254.
Takagi M, Delia D, Chessa L, Iwata S, Shigeta T, Kanke Y, Goi K, Asada M, Eguchi M, Kodama C and Mizutani S . (1998). Cancer Res., 58, 4923–4929.
Tibbetts RS, Brumbaugh KM, Williams JM, Sarkaria JN, Cliby WA, Shieh SY, Taya Y, Prives C and Abraham RT . (1999). Genes Dev., 13, 152–157.
Woo RA, Jack MT, Xu Y, Burma S, Chen DJ and Lee PW . (2002). EMBO J., 21, 3000–3008.
Yoshida M, Hosoi Y, Miyachi H, Ishii N, Matsumoto Y, Enomoto A, Nakagawa K, Yamada S, Suzuki N and Ono T . (2002). Int. J. Radiat. Biol., 78, 503–512.
Acknowledgements
This work was financially supported by grants of the Italian Association for Cancer Research (AIRC) and Telethon grants E764 and GPO205/01.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Delia, D., Fontanella, E., Ferrario, C. et al. DNA damage-induced cell-cycle phase regulation of p53 and p21waf1 in normal and ATM-defective cells. Oncogene 22, 7866–7869 (2003). https://doi.org/10.1038/sj.onc.1207086
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1207086
This article is cited by
-
Raltitrexed increases radiation sensitivity of esophageal squamous carcinoma cells
Cancer Cell International (2019)
-
Effects of tumor-suppressor lysyl oxidase propeptide on prostate cancer xenograft growth and its direct interactions with DNA repair pathways
Oncogene (2015)
-
Effect and Mechanism of Resveratrol on the Apoptosis of Lung Adenocarcinoma Cell Line A549
Cell Biochemistry and Biophysics (2015)
-
Widdrol activates DNA damage checkpoint through the signaling Chk2–p53–Cdc25A–p21–MCM4 pathway in HT29 cells
Molecular and Cellular Biochemistry (2012)
-
Tumor response to radiotherapy is dependent on genotype-associated mechanisms in vitro and in vivo
Radiation Oncology (2010)